{"id":"W2909533581","doi":"10.1016/j.eururo.2019.01.009","title":"Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma","year":2019,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Concomitant; Pembrolizumab; Radiation therapy; Adverse effect; Oncology; Common Terminology Criteria for Adverse Events; Internal medicine; Tolerability; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006950473,0.0007098994,0.002965046,0.0005034471,0.00003357852,0.00002461322,0.0003235195,0.0002803374,0.0007218785],"category_scores_gemma":[0.0001591782,0.0005169904,0.0005355025,0.0001841706,0.0004934624,0.00006566199,0.00005200184,0.001523495,0.0001023509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002102284,"about_ca_system_score_gemma":0.0008213546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002062886,"about_ca_topic_score_gemma":0.00000948486,"domain_scores_codex":[0.9934053,0.003432604,0.001121825,0.000834945,0.0005441756,0.0006611903],"domain_scores_gemma":[0.997112,0.001062984,0.0007068337,0.0009107045,0.0001099,0.00009754858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9642394,0.0005879709,0.00005866185,0.0002083411,0.002629426,0.009428021,0.0003285416,0.000003629252,0.0002248433,0.00001267152,0.02202243,0.0002560698],"study_design_scores_gemma":[0.8768454,0.01992195,0.00005051715,0.00005289863,0.003151425,0.0004155323,0.000007407994,0.00007666104,0.0000750019,0.000006241033,0.09904454,0.0003524862],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7770995,0.003740168,0.0004711619,0.1404867,0.009362997,0.02069587,0.0008125606,0.000221918,0.04710907],"genre_scores_gemma":[0.8529542,0.0002310682,0.0001879273,0.1381348,0.004790102,0.0001935696,0.0006123051,0.0004408805,0.002455085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08739405,"threshold_uncertainty_score":0.9997281,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03970726362905173,"score_gpt":0.316673709177014,"score_spread":0.2769664455479623,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}